Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Abstract Text:

    The purpose of this study is to estimate the maximum-tolerated dose (MTD) and describe toxicities and preliminary clinical effects of tipifarnib, a farnesyltransferase (FTase) inhibitor, administered concurrently with radiation therapy in children with newly diagnosed intrinsic diffuse brainstem glioma (BSG). Children >/=3 and

    Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Neuro-oncology

    VOLUME: 10

    Page Numbers: 341-7

    Journal Abbreviation: Neuro-oncology

    ISSN: 1522-8517

    DAY: 16

    MONTH: 04

    YEAR: 2008

    Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100887420

    Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.

    AFFILIATION: Department of Radiation Oncology, 1600 Divisadero St., Suite H1031, San Francisco, CA 94115-1708. hkogan@radonc17.ucsf.edu.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Neuro Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News